17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway

Wang,Huan; Liu,Yan; Zhu,Ling; Wang,Wenjing; Wan,Zhaofei; Chen,Fangyuan; Wu,Yan; Zhou,Juan; Yuan,Zuyi

doi:10.3892/ijmm.2014.1619

17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway

Authors:
- Huan Wang
- Yan Liu
- Ling Zhu
- Wenjing Wang
- Zhaofei Wan
- Fangyuan Chen
- Yan Wu
- Juan Zhou
- Zuyi Yuan
View Affiliations

Affiliations: Department of Cardiovascular Medicine, The First Affiliated Hospital of the Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: January 8, 2014 https://doi.org/10.3892/ijmm.2014.1619
Pages: 550-558

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Estrogen has pleiotropic effects on the cardiovascular diseases, yet the underlying mechanisms remain incompletely understood. Cholesterol efflux is a key mechanism through which to prevent foam cell formation and the development of atherosclerosis. Recent studies highlight the role of vascular smooth muscle cell (VSMC)-derived foam cells in atherogenesis. However, it remains unclear whether estrogen promotes cholesterol efflux from VSMCs and inhibits VSMC-derived foam cell formation. In the present study, we demonstrated that 17β-estradiol (E2) markedly enhanced cholesterol efflux to apolipoprotein (apo)A-1 and high-density lipoprotein (HDL) and attenuated oxidized low-density lipoprotein (ox-LDL) induced cholesteryl ester accumulation in VSMCs, which was associated with an increase in the expression of ATP-binding cassette transporters ABCA1 and ABCG1. The upregulation of ABCA1 and ABCG1 expression by E2 resulted from liver X receptor (LXR)α activation, which was confirmed by the prevention of the expression of ABCA1 and ABCG1 after inhibition of LXRα with a pharmacological inhibitor or small interfering RNA (siRNA). Furthermore, E2 increased LXRα, ABCA1 and ABCG1 expression in VSMCs via the estrogen receptor (ER), and the involvement of ERβ was confirmed by the use of selective ERα or ERβ antagonists (MPP and PHTPP) and agonists (PPT and DPN). These findings suggest that E2 promotes cholesterol efflux from VSMCs and reduces VSMC-derived foam cell formation via ERβ- and LXRα-dependent upregulation of ABCA1 and ABCG1 and provide novel insights into the anti-atherogenic properties of estrogen.

View Figures

View References

1	Weber C and Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 17:1410–1422. 2011. View Article : Google Scholar : PubMed/NCBI
2	Meyer MR, Haas E and Barton M: Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 47:1019–1026. 2006. View Article : Google Scholar : PubMed/NCBI
3	Hodgin JB and Maeda N: Minireview: estrogen and mouse models of atherosclerosis. Endocrinology. 143:4495–4501. 2002. View Article : Google Scholar : PubMed/NCBI
4	Kavanagh K, Davis MA, Zhang L, et al: Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys. Arterioscler Thromb Vasc Biol. 29:1471–1477. 2009. View Article : Google Scholar : PubMed/NCBI
5	Ribas V, Drew BG, Le JA, et al: Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA. 108:16457–16462. 2011.
6	Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:605–613. 1998. View Article : Google Scholar
7	Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 288:321–333. 2002.PubMed/NCBI
8	Rosenson RS, Brewer HB Jr, Davidson WS, et al: Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation. 125:1905–1919. 2012. View Article : Google Scholar : PubMed/NCBI
9	Saeed O, Otsuka F, Polavarapu R, et al: Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol. 32:299–307. 2012. View Article : Google Scholar : PubMed/NCBI
10	Wang X, Collins HL, Ranalletta M, et al: Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest. 117:2216–2224. 2007. View Article : Google Scholar : PubMed/NCBI
11	Wang X, Liao D, Bharadwaj U, Li M, Yao Q and Chen C: C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol. 28:519–526. 2008. View Article : Google Scholar : PubMed/NCBI
12	Ma L, Zhong J, Zhao Z, et al: Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc Res. 92:504–513. 2011. View Article : Google Scholar : PubMed/NCBI
13	Allahverdian S, Pannu PS and Francis GA: Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res. 95:165–172. 2012. View Article : Google Scholar : PubMed/NCBI
14	Stary HC, Chandler AB, Glagov S, et al: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 14:840–856. 1994. View Article : Google Scholar
15	Rong JX, Shapiro M, Trogan E and Fisher EA: Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA. 100:13531–13536. 2003. View Article : Google Scholar : PubMed/NCBI
16	Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, Galper JB and Beasley D: Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 31:50–57. 2011. View Article : Google Scholar : PubMed/NCBI
17	Ueda K, Lu Q, Baur W, Aronovitz MJ and Karas RH: Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol. 33:1837–1843. 2013. View Article : Google Scholar : PubMed/NCBI
18	Jiang X, Zhang Y, Hou D, et al: 17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression. Mol Cell Endocrinol. 315:74–80. 2010. View Article : Google Scholar : PubMed/NCBI
19	Jiang P, Xu J, Zheng S, et al: 17β-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells. J Mol Endocrinol. 45:87–97. 2010.
20	Metz RP, Patterson JL and Wilson E: Vascular smooth muscle cells: isolation, culture, and characterization. Methods Mol Biol. 843:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
21	Tsai JY, Su KH, Shyue SK, et al: EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res. 88:415–423. 2010. View Article : Google Scholar : PubMed/NCBI
22	Han X, Kitamoto S, Lian Q and Boisvert WA: Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J Biol Chem. 284:32950–32958. 2009. View Article : Google Scholar : PubMed/NCBI
23	Park SH, Kim JL, Kang MK, et al: Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages. Int J Mol Med. 30:1105–1112. 2012.
24	Yuan Y, Li P and Ye J: Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell. 3:173–181. 2012. View Article : Google Scholar : PubMed/NCBI
25	Rivera J, Walduck AK, Thomas SR, et al: Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1. Naunyn Schmiedebergs Arch Pharmacol. 386:1081–1093. 2013. View Article : Google Scholar : PubMed/NCBI
26	Xue JH, Yuan Z, Wu Y, et al: High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res. 86:141–150. 2010. View Article : Google Scholar : PubMed/NCBI
27	Choi HY, Rahmani M, Wong BW, et al: ATP-binding cassette transporter A1 expression and apolipoprotein AI binding are impaired in intima-type arterial smooth muscle cells. Circulation. 119:3223–3231. 2009. View Article : Google Scholar : PubMed/NCBI
28	Klouche M, Rose-John S, Schmiedt W and Bhakdi S: Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation. 101:1799–1805. 2000. View Article : Google Scholar : PubMed/NCBI
29	Nofer JR: Estrogens and atherosclerosis: insights from animal models and cell systems. J Mol Endocrinol. 48:R13–R29. 2012. View Article : Google Scholar : PubMed/NCBI
30	Ghosh S, Zhao B, Bie J and Song J: Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul Pharmacol. 52:1–10. 2010. View Article : Google Scholar : PubMed/NCBI
31	Yvan-Charvet L, Wang N and Tall AR: Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 30:139–143. 2010. View Article : Google Scholar : PubMed/NCBI
32	Zhao C and Dahlman-Wright K: Liver X receptor in cholesterol metabolism. J Endocrinol. 204:233–240. 2010. View Article : Google Scholar : PubMed/NCBI
33	Yan JQ, Tan CZ, Wu JH, et al: Neopterin negatively regulates expression of ABCA1 and ABCG1 by the LXRα signaling pathway in THP-1 macrophage-derived foam cells. Mol Cell Biochem. 379:123–131. 2013.PubMed/NCBI
34	Corcoran MP, Lichtenstein AH, Meydani M, Dillard A, Schaefer EJ and Lamon-Fava S: The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu. J Mol Endocrinol. 47:109–117. 2011.
35	Cerda A, Issa MH, Genvigir FD, et al: Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women. J Steroid Biochem Mol Biol. 138:403–409. 2013. View Article : Google Scholar : PubMed/NCBI
36	Kramer P and Wray S: 17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis. J Steroid Biochem Mol Biol. 81:203–216. 2002. View Article : Google Scholar : PubMed/NCBI
37	Srivastava RA: Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem. 240:67–73. 2002. View Article : Google Scholar : PubMed/NCBI
38	Liang X, He M, Chen T, et al: 17β-estradiol suppresses the macrophage foam cell formation associated with SOCS3. Horm Metab Res. 45:423–429. 2013.
39	Murphy E: Estrogen signaling and cardiovascular disease. Circ Res. 109:687–696. 2011. View Article : Google Scholar
40	Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O and Maeda N: Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe^−/−mice. J Clin Invest. 107:333–340. 2001.
41	Villablanca AC, Tenwolde A, Lee M, Huck M, Mumenthaler S and Rutledge JC: 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res. 2:289–299. 2009. View Article : Google Scholar : PubMed/NCBI
42	Rayner K, Sun J, Chen Y-X, et al: Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor beta modulation. Arterioscler Thromb Vasc Biol. 29:1751–1756. 2009. View Article : Google Scholar : PubMed/NCBI
43	Xing D, Feng W, Miller AP, et al: Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol. 292:H2607–H2612. 2007. View Article : Google Scholar : PubMed/NCBI